HCID 178511956, compound → HCID 178511954, compound

HRID 1752936Notes

Reaction equation

HRID 1752936 reaction equation
[OH:1][C:2]1[C:7]([C:8]2[NH:12][C:11]3[CH:13]=[CH:14][C:15]([C:17]([NH2:19])=[NH:18])=[CH:16][C:10]=3[N:9]=2)=[CH:6][C:5]([S:20](=[O:33])(=[O:32])[NH:21][C:22](=[O:31])[CH2:23][CH2:24][C:25]2[CH:26]=[N:27][CH:28]=[CH:29][CH:30]=2)=[CH:4][C:3]=1[C:34]1[CH:39]=[CH:38][CH:37]=[C:36]([N+:40]([O-])=O)[CH:35]=1>FC(F)(F)C(O)=O.O=[Pt]=O>[NH2:40][C:36]1[CH:35]=[C:34]([C:3]2[CH:4]=[C:5]([S:20](=[O:33])(=[O:32])[NH:21][C:22](=[O:31])[CH2:23][CH2:24][CH:25]3[CH2:30][CH2:29][CH2:28][NH:27][CH2:26]3)[CH:6]=[C:7]([C:8]3[NH:12][C:11]4[CH:13]=[CH:14][C:15]([C:17]([NH2:19])=[NH:18])=[CH:16][C:10]=4[N:9]=3)[C:2]=2[OH:1])[CH:39]=[CH:38][CH:37]=1

Participants

4

Procedure

2-[2-Hydroxy-3′-nitro-5-(3-pyridin-3-yl-propionylsulfamoyl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine (0.031 g, 0.05 mMol), prepared as in Example 10, was dissolved in trifluoroacetic acid (5 mL) and the solution was subjected to hydrogenation at 50 psi over PtO2 catalyst for 12 hours. The mixture was concentrated in vacuum and product was purified from the residue by reverse phase HPLC (acetonitrile gradient) to give 2-[3′-amino-2-hydroxy-5-(3-piperidin-3-yl-propionylsulfamoyl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine (0.01 g). MS. found (M+H+) 562.4, (M−H+) 560.6, calc. 561.22.

Workup

  1. concentrationThe mixture was concentrated in vacuum and product
  2. customwas purified from the residue by reverse phase HPLC (acetonitrile gradient)

Sources & evidence

ORD record
ord-5ae1e07b7b6e45ca94297d42ffc61685
Source dataset
uspto-grants-2015_10
Patent number
US09162986B2

Reaction notes

Loading…